The Ca 2؉ -binding proteins KChIP1-4 (KChIP3 is also known as DREAM and calsenilin) act as auxiliary subunits for voltage-gated K ؉ channels in the Kv4 family. Here we identify three splicing isoforms of rat KChIP2 with variable N-terminal peptides. The two longer isoforms, which contain the 32-amino acid peptide, produce larger increases in Kv4.3 protein level and current density and more effectively localize themselves and their associated channels at the plasma membrane than the shortest variant. The 32-amino acid peptide contains potential palmitoylation cysteines. Metabolic labeling demonstrates that these cysteines in the KChIP2 isoforms, as well as the corresponding sites in KChIP3, are palmitoylated. Mutating these cysteines reduces their plasma membrane localization and the enhancement of Kv4.3 current density. Thus, palmitoylation of the KChIP auxiliary subunits controls plasma membrane localization of their associated channels.
Diverse voltage-gated K ϩ channels differentially influence excitability in neurons, cardiac myocytes, and other types of cells. Molecular cloning and electrophysiological studies have shown that the presence of various K ϩ currents in mammalian cells is primarily attributable to the expression of multiple channel subunit genes that encode channels with distinct electrical properties. Kv4 channel genes (Kv4.1, Kv4.2, and Kv4. 3) encode channels that are activated at subthreshold of action potentials and rapidly inactivate (1) (2) (3) (4) . Studies with a dominant-negative subunit (5) and antisense oligonucleotides (6) have demonstrated that these genes encode a large fraction of the rapidly inactivating K ϩ channels in certain neurons and cardiac myocytes. Immunohistochemical studies show somatodendritic localization of Kv4 channel proteins (7) (8) (9) . Thus, it is likely that Kv4 channels carry a large portion of the somatodendritic A current in neurons. This current influences action potential propagation and frequency (10) . In cardiac myocytes, transient outward K ϩ current is important for the early phase of repolarization and sets distinct action potential waveforms in different regions of the heart. Thus, Kv4 channels play crucial roles in integrating synaptic inputs and setting the shape and frequency of action potentials in neurons and cardiac myocytes.
Recent molecular genetic studies revealed that many K ϩ channels are composed of not only their pore-forming subunits but are associated with various auxiliary subunits and/or other interacting proteins. The expression and localization of Kv4 channels can be regulated by various channel-interacting proteins including Kv␤ subunits (11, 12) , MiRP1 (13) , the chaperon-like proteins KChAPs (14) , and the cytoskeleton-associated proteins filamins (15) . More recently, a class of EF hand-containing Ca 2ϩ -binding proteins (K ϩ channel-interacting proteins (KChIPs)) 1 has been identified as physiologically important auxiliary subunits for Kv4 channels (16) . KChIPs are encoded by at least four genes, KChIP1-4, and consist of a conserved core region and a variable N-terminal peptide (16, 17) . The core region contains four EF hand motifs. The last three EF hand motifs of KChIP3 have been shown to bind to Ca 2ϩ (18) . All four KChIP genes are expressed highly in brain, whereas only KChIP2 mRNA is abundant in heart (16, 17) . Association with these channel-interacting proteins dramatically increases current amplitude and alters the gating properties of Kv4 channels. Kv4-KChIP complexes exhibit some of the gating properties (16, 19 -22) and the modulation by arachidonic acid (23) which are reminiscent of native transient K ϩ currents in neurons and cardiac myocytes. Finally, deletion of the KChIP2 gene leads to a complete loss of transient outward K ϩ current in ventricular cardiac myocytes (24) . These findings indicate that KChIPs are essential components of these rapidly inactivating K ϩ channels in excitable cells. Although it is clear that KChIPs are present in association with Kv4 channels to regulate their expression and gating in vivo, some or all KChIPs may also act as transcription factors and regulators of the Alzheimer's disease-associated proteins presenilins. KChIP3 has been shown to inhibit transcription of the prodynorphine gene by interacting with the DNA element in its 5Ј-untranslated region in an intracellular Ca 2ϩ concentration-dependent manner and therefore was named downstream regulatory element-antagonist modulator (DREAM) (25) . KChIP3 is also known as calsenilin, because this protein was shown to interact with the C terminus of the Alzheimer's disease-associated presenilins (26) . Thus, KChIP3, as well as other KChIPs, may participate in multiple cellular responses.
To elucidate how KChIPs regulate Kv4 channels and other cellular processes, we isolated cDNAs for various KChIP gene products. In this paper, we show that KChIP2 splicing isoforms influence Kv4.3 channel gating in a similar manner but exhibit differential enhancement of channel expression and subcellular localization. These differences appear to be primarily due to palmitoylation of the N-terminal peptide which is present only in the longer isoforms. Palmitoylation of KChIP3 at the corresponding sites is similarly required for efficient plasma membrane localization and up-regulation of functional channel expression. These results indicate that palmitoylation is an important mechanism to control the subcellular localization of complexes containing these potentially multifunctional Ca 2ϩ -binding proteins.
MATERIALS AND METHODS
Isolation of Rat KChIP2 cDNAs-Rat KChIP2 cDNAs were obtained using RT-PCR with primers that were designed based on the published human KChIP2 sequence (16) . First-strand cDNAs were prepared with total RNA isolated from whole brain and heart of female adult (ϳ9 weeks old) Sprague-Dawley rats using thermoscript reverse transcriptase (Invitrogen). PCR with one set of primers (the 5Ј end primer, 5Ј-ATGCGGGGCCAGGGCCGCAAGGA-3Ј; the 3Ј end primer, 5Ј-CTA-GATGTCATTGTCAAAGAGCTCCAT-3Ј) generated clear multiple products in the molecular size range expected from the human sequence. The PCR products were cloned into pGEM T-vector Easy (Promega). The obtained clones were classified into three groups due to restriction enzyme digestion patterns. At least four clones from each group were sequenced.
Constructions-KChIP2 cDNAs were cloned into pcDNA3 (Invitrogen) and Emerald-C1 using NcoI and SalI sites in the polylinker region of pGEM T-vector Easy. Emerald-C1 vector was constructed by replacing EGFP of EGFP-C1 (CLONTECH) with Emerald (Packard Instrument Co.) by a PCR-based method. Briefly, KChIP2 cDNA clones were digested with NcoI, blunt-ended with Klenow, and cut with SalI. The obtained fragments were subcloned into blunt-ended EcoRI-XhoI site of pcDNA3 and blunt-ended HindIII-SalI site of Emerald-C1. The resulting Emerald constructs contain a 17-amino acid peptide with the sequence SGLRSRAQAHGGRGNSI between Emerald and KChIP. Myctagged Kv4.3 cDNA was constructed by introducing an EcoRI site in front of the initiation methionine of Kv4.3 using site-directed mutagenesis (Stratagene), followed by subcloning a full-length Kv4.3 cDNA into EcoRI-XbaI site of pCS2ϩMT. The obtained construct contains six Myc tags at the N terminus of the Kv4.3 polypeptide.
PCR Analysis for Splicing Isoforms-Total RNA was isolated using one-step extraction with acid phenol chloroform guanidium thiocyanate, and RNA concentrations were determined spectrophotometrically. First strand cDNAs were prepared from the isolated total RNA with an oligo(dT) 18 primer using thermostable reverse transcriptase (Invitrogen). PCR for KChIP2 splicing variants was performed with oligonucleotides (5Ј-GCTCCTATGACCAGCTTACGG-3Ј and 5Ј-CCTCGTTGACAATCCCACTGG-3Ј) as follows: 94°C for 15 s, 64°C for 15 s, and 68°C for 1.5 min ϩ 10 s/cycle for 22 cycles and that for glyceraldehyde-3-phosphate dehydrogenase was done with primers (5Ј-GCCATCACTGCCACTCAG-3Ј and 5Ј-GTGAGCTTCCCGTTCAGC-3Ј) for 14 cycles. Obtained products were separated on an 1.5% agarose gel and stained with ethidium bromide.
Immunoblot Analysis-CHO cells were cultured in Ham's F-12 medium supplemented with 10% fetal bovine serum. Cells on an 100-mm plastic dish were transfected with Myc-tagged Kv4.3 cDNA (2 g), KChIP2 cDNA, or empty vector (10 g) and Emerald-C1 (0.5 g) using LipofectAMINE-PLUS (Invitrogen). Immediately after transfection, cells were passed using trypsin/EDTA solution into 60-mm plastic dishes at various densities. Various days after transfection, cells were harvested with ice-cold phosphate-buffered saline. Cell extract was prepared with modified RIPA buffer (1% Triton X-100, 0.5% sodium deoxycholate, 0.2% SDS, 1 mM iodoacetamide, 0.2 mM phenylmethylsulfonyl oxide, 1 mM EDTA, and 20 mM Tris-HCl (pH 7.5)).
Protein concentration was determined by modified Lowry method (Invitrogen) with bovine serum albumin as a standard. Immunoblot analysis was performed following SDS-PAGE with polyclonal anti-Myc, anti-GFP (MBL International), or anti-KChIP2 antibodies as described previously (12) . Anti-KChIP2 antibody was generated against a synthetic peptide containing the first 25 amino acids of the protein and was affinity-purified. Chemiluminescent images were captured and analyzed using a CCD camera-based system (Ultraviolet Products).
Patch Clamp Recording-CHO cells on a 35-mm plastic dish were transfected with expression constructs for Kv4.3 (0.05 g), KChIP2, or empty vector (0.25 g) and Emerald-C1 (0.05 g). The EGFP construct was included for identification of transfected cells. Two days after transfection, whole-cell voltage clamp recording was performed with an EPC-9 patch clamp amplifier using the Pulse program (HEKA) or with Axopatch-1D patch clamp amplifier using pClamp software. Pipettes were filled with a solution containing 140 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, and 10 mM HEPES (pH 7.4). Bath solution contained 155 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 20 mM glucose, and 10 mM HEPES (pH 7.4). Leak currents were subtracted by P/4 protocol, and series resistance was set at 70%.
Peak currents were converted into conductance (G) by the formula G ϭ I/(V m Ϫ V rev ), where I is the measured membrane current, V m is the voltage step, and V rev is the potassium reversal potential, which was calculated to be Ϫ84 mV. For activation and steady state inactivation analyses, the half-maximal voltage (V1 ⁄2 ) and the slope factor (k) were acquired using the modified Boltzmann equation
where G is the conductance; G max is the fitted maximal conductance, and V is the command potential. For recovery from inactivation, the data were fitted with one and two exponentials, and fitness was evaluated by F test using the Prism program (GraphPad). In all the cases, the data were better described with one exponential, and constants were obtained using these equations.
Metabolic Labeling-One day after transfection, CHO cells on a 100-mm dish transfected with Kv4.3 and GFP-KChIP cDNAs (5:1 cDNA ratio) were metabolically labeled with 1 mCi of [
3 H]palmitic acid in the standard medium supplemented with extra sodium pyruvate (200 mg/ liter) for 4 h. Cell extracts were prepared, and immunoprecipitation was performed with anti-GFP antibody, as described previously (12, 27) , except that the solutions for binding and washing were done with the modified RIPA buffer. Precipitated materials were separated on a 10% SDS gel and subjected to fluorographic exposure. A small portion of the precipitates was used for immunoblotting with anti-GFP antibody.
Immunostaining and Confocal Microscopy-HEK293 cells on a polylysine-coated glass coverslip in a 35-mm plastic dish were transfected using calcium phosphate precipitation with Emerald-KChIP2 expression vector (0.05 g) and Kv4.3 cDNA expression construct or empty vector (0.25 g) for GFP imaging, or with myc-Kv4.3 cDNA (0.1 g) and KChIP2 pcDNA or empty vector (0.5 g) for immunostaining. Two days after transfection, confocal images were taken directly (GFP imaging) or following immunostaining on an Amersham Biosciences 2001 scanning laser microscope as described previously (12) . For immunostaining, cells were fixed with 4% formaldehyde in phosphate-buffered saline supplemented with 0.1% Triton X-100 for 20 min at room temperature. Cell dishes were coated with 5% nonfat-dry milk in the same solution and probed with Cy3-conjugated anti-Myc antibody. Plasma membrane or surface expression was evaluated by comparing location of fluorescence with bright field images of cells.
Statistical Analysis-Statistical analysis was carried out using Mann-Whitney two-tailed test, and p Ͻ 0.05 was considered to be significant. All the data in this work are presented as means Ϯ S.E.
RESULTS

KChIP2 Splicing Isoforms Are Differentially Expressed in
Brain and Heart Tissues-To obtain rat KChIP2 cDNAs, we performed RT-PCR with primers that were designed based on the published human sequence (16) . PCR with one set of primers using RNAs from adult rat brain or heart as starting materials produced multiple fragments in the expected molecular size range. Cloning and sequencing of these PCR products revealed the presence of three rat KChIP2 splicing isoforms (Fig. 1A) . The longest isoform contains an additional 32-amino acid peptide not present in the human sequence, whereas the shortest variant lacks an 18-amino acid peptide. The identical KChIP2 isoforms have recently been isolated from several species (20, 22, 28) . We named these long, medium, and short isoforms KChIP2a, -2b, and -2c, respectively. Rat KChIP2b shows ϳ97% amino acid identity to its human counterpart.
Previous work (16) has shown that KChIP2 mRNA is abundantly expressed in rat brain and heart. High levels of Kv4 channel mRNAs and proteins have also been found in these two organs (1, 29, 30) . To test for differential expression of the identified KChIP2 splicing isoforms in various regions of these two organs, we used RT-PCR with primers that correspond to the common N-terminal and core regions of the rat KChIP2 sequence (Fig. 1B) . In brain, KChIP2 mRNA was abundant in striatum, hippocampus, and olfactory bulb, was moderate in cerebral cortex, and was low in thalamus and hypothalamus. No significant PCR product for any KChIP2 variants was detected in pituitary or skeletal muscle (data not shown) even after extended cycles (40 cycles). In cerebral cortex, striatum, and hippocampus, the longest KChIP2a seemed a predominant form, whereas all three isoforms were equally expressed in the olfactory bulb. Unlike region-selective expression in the brain, the auxiliary subunit mRNAs were abundant throughout the heart tissues. Specifically, no differential expression of any KChIP2 isoform mRNA was found between the right and left ventricles or across the left ventricular wall. In contrast to the abundant expression of the longest variant in the brain, the two shorter isoforms, KChIP2b and -2c, predominated in these tissues. Thus, KChIP2 splicing isoforms are differentially expressed in brain and heart tissues.
KChIP2 Splicing Isoforms Differentially Enhance Expression of Kv4.3 Channels-Many auxiliary subunits or interacting proteins for K ϩ channels increase current density and/or channel protein levels. To test whether the identified KChIP2 splicing variants might differentially influence the expression of Kv4 channels, we first measured Kv4.3 channel protein levels upon coexpression of each splicing isoform (Kv4.3:KChIP ϭ 1:5) in CHO cells (Fig. 2, A and B) . All KChIP2 splicing variants significantly increased Kv4.3 protein levels. KChIP2a and -2b produced significantly larger increases (ϳ3-fold) than KChIP2c (ϳ1.6-fold). These fold increases in channel protein level were similar between 1 and 4 days after transfection. KChIP protein levels detected with antibody raised against the first 25 amino acids of the rat KChIP2 peptide were similar for all variants (within 25% of deviations in all experiments, data not shown). Furthermore, increasing amounts of KChIP2c (Kv4.3:KChIP ϭ 1:10) did not cause further enhancement (data not shown). Thus, the two isoforms with a longer N terminus more potently facilitate the expression of Kv4.3 channel proteins.
Next we examined if the observed increases in channel protein level were correlated with functional channel expression (Fig. 2, C and D) . Similar to the effects on channel protein level, patch clamp recording revealed that the two longer isoforms produced larger increases in Kv4.3 current density than the shortest variant. Coexpression of excess KChIP2a, -2b, and -2c (Kv4.3:KChIP2 cDNA ratio ϭ 1:5) resulted in ϳ4.0-, ϳ3.2-, and ϳ1.6-fold increases in current density, respectively. Thus, the two longer KChIP2 variants more effectively enhanced the expression of functional Kv4.3 channels than the shortest isoform.
In contrast to the differential increases in functional channel expression, the three variants similarly influenced the gating of associated Kv4.3 channels (Fig. 3 and Table I ). Coexpression of any KChIP2 splicing variants resulted in significantly slower inactivation with test pulses at higher voltages (Fig. 3B) . Likewise, all three isoforms caused significantly faster and more complete recovery from inactivation (Fig. 3D) . The only notable difference among the KChIP2 variant-induced changes in Kv4.3 channel gating was that KChIP2a, but not other two isoforms, produced a marginal shift to the left in the voltage dependence of activation (Fig. 3A) . Thus, the three KChIP2 splicing isoforms produce similar changes in Kv4.3 channel gating in transfected CHO cells. These results indicate that the observed differential enhancement of current density by the splicing variants is not due to altered Kv4.3 channel gating but to the number or conductance of functional channels. Taken together with the differential increases in channel protein level, we concluded that the two longer KChIP2 isoforms more potently enhance functional Kv4.3 channel expression by producing larger increases in the number of functional channels at the cell surface.
KChIP2 Splicing Isoforms Exhibit Differential Cell Surface Localization-Because the KChIP2 splicing variants differentially increased the expression of functional Kv4.3 channels, we wondered if these isoforms might differ in their ability to control channel protein trafficking. To address this question, we first examined subcellular localization of KChIP2 variants by using GFP as a tag. Because the flat shape of CHO cells makes the detection of the cell surface localization of proteins difficult, we used HEK293 cells for this purpose. GFP-tagged KChIPs were expressed in HEK293 cells in the presence or absence of Kv4.3 proteins (Fig. 4A) . Even in the absence of Kv4.3 proteins, significant GFP-KChIP2a and -2b were found at the plasma membrane, and weak fluorescence was seen throughout the cell. Expression of excess Kv4.3 proteins intensified the fluorescence of these GFP-tagged subunits at the plasma membrane, and less diffuse fluorescence was observed inside the cell. In contrast, no significant plasma membrane fluorescence was detected with GFP-KChIP2c in the absence of Kv4.3 protein. Coexpression with Kv4.3 proteins localized GFP-KChIP2c to the plasma membrane and other intracellular compartments. Compared with the two longer isoform fusion proteins, FIG. 1. KChIP2 splicing isoforms are differentially expressed in brain and heart tissues. A, sequence alignment indicates that the published human KChIP2 corresponds to rat KChIP2b. * represents identical amino acids between rKChIP2b and hKChIP, and : and . indicate high and low sequence similarities, respectively. B, expression of KChIP2 splicing isoforms in brain and heart tissues was examined by RT-PCR analysis. KChIP2a, -b, and -c correspond to the products with 324, 270, and 174 bp, respectively. more intracellular accumulation was evident with GFPKChIP2c. Thus, KChIP2a and -2b, but not -2c, have the ability to localize to the plasma membrane without coexpression of Kv4.3 channels. This ability may contribute to the observed larger increases in the expression of functional Kv4.3 channels.
Next we tested if the KChIP2 splicing variants might differentially localize their associated channels at the plasma membrane by using immunostaining with Myc-tagged Kv4.3 proteins (Fig. 4B) . In the absence of any KChIP2 variant, Kv4.3 proteins were rather diffusely distributed throughout the cell, and only a few cells (Ͻ5%) exhibited clear cell surface localization. When excess KChIP2a or -2b was coexpressed, the channel proteins were found at the cell surface in the majority of transfected cells. In contrast, less apparent surface localization of the channel protein was seen with KChIP2c. These results indicate that the two longer KChIP2 isoforms more effectively localize associated channels to the plasma membrane than the shortest variant.
Palmitoylation of the N-terminal Cysteines of KChIPs Is Required for Efficient Cell Surface Localization and Enhancement of Kv4.3 Channel Expression-Because
KChIP2a and -2b, but not KChIP2c, were effective in localizing themselves and their associated channels at the plasma membrane, the 32-amino acid peptide that is present in the two longer isoforms might be responsible for the observed differences. This peptide exhibits similarity to a part of the C-terminal region of the G proteincoupled receptor kinase GRK6 (Fig. 5A, top) . The cysteine residues in this part of the kinase are known to be palmitoylated (31) . In addition to the KChIP2 isoforms, we also detected potential palmitoylation sites in the N-terminal regions of KChIP3 and the longer isoform of KChIP4 (17) (Fig. 5A, bottom) . Because palmitoylation is known to be involved in plasma membrane localization, the fatty acylation of these cysteines in KChIP2a and -2b, as well as other KChIPs, might be required for their effective enhancement of channel expression and plasma membrane localization. To test this possibility, we mutated the cysteines in KChIP2b, as well as the corresponding residues in KChIP3. Replacing the two cysteines of KChIP2b with alanine (C45A,C46A) or serine (C45S,C46S, data not shown) eliminated its ability to localize to the plasma membrane in the absence of associating channels (Fig. 5B) . When excess Kv4.3 channels were coexpressed, this C45A,C46A mutant was localized at the plasma membrane and intracellular compartments. More intracellular accumulation was seen with the mutant than the wild type. Wild-type GFP-KChIP3 did not show apparent localization to the plasma membrane in the absence of associating channels. However, when Kv4.3 channels were coexpressed, this fusion protein was detected at the Various days after transfection, cells were harvested, and immunoblot analysis was performed. Representative blots with anti-Kv4.3 antibody (top) and with anti-GFP antibody (bottom) are shown. myc-Kv4.3, as well as Kv4.3 without a tag, were routinely seen as high molecular weight aggregates and the band at the expected size. The molecular mass of myc-Kv4.3 is calculated to be ϳ83 kDa; however, the major myc-Kv4.3 protein band on the gel appears to be ϳ95 kDa. Similar increases in apparent molecular sizes were observed with other fusion proteins containing this Myc tag. B, immunoreactivities of the 95-kDa myc-Kv4.3 and GFP proteins were determined by measuring chemiluminescence intensity. Points and error bars represent mean and S.E., respectively (n ϭ 4 for each point). Kv4.3 protein levels were significantly larger in cells transfected with KChIP2a, -2b, or -2c than those without any KChIP2 in all time points (2a or 2b) or in the 1st and 2nd days (2c) (p Ͻ 0.05). Also, Kv4.3 protein levels with KChIP2a or -2b were significantly larger than those with KChIP2c between day 1 and 3 (p Ͻ 0.05). C, CHO cells were similarly transfected with expression constructs for Kv4.3 and KChIP2 or empty vector (None). Two days after transfection, K ϩ current was measured by patch clamp recording. K ϩ currents were elicited by 200-ms depolarization pulses (from Ϫ40 to 50 mV in 10-mV increments) from a holding potential of Ϫ70 mV. Representative current traces are shown. D, peak current density-voltage relationships are shown. Points and error bars indicate mean and S.E., respectively (n Ͼ6 for each point). Peak current density was larger in cells transfected with KChIP2a, -2b, or -2c than those without any auxiliary subunits at voltages higher than Ϫ20 mV (p Ͻ 0.05). Also, current density in cells with KChIP2a or -2b was significantly larger than those with KChIP2c at voltages higher than Ϫ10 mV (p Ͻ 0.05).
plasma membrane as well as in other intracellular compartments. Mutating the two cysteines in KChIP3 with alanine (C47A,C48A) or serine (C47S,C48S, data not shown) markedly reduced plasma membrane localization in the presence of the channels. The changes in localization produced by these cysteine mutations were not due to the lack of association, as demonstrated by coimmunoprecipitation (Fig. 5C) . Finally, metabolic labeling with [ 3 H]palmitic acid revealed that these cysteines were indeed palmitoylated (Fig. 5D) . Thus, palmitoylation of the N termini of KChIP2 and -3 is required for their efficient plasma membrane localization.
Patch clamp recording was then used to examine the effects of the cysteine mutations on functional channel expression (Fig. 6) . Wild-type KChIP2b and -3 increased Kv4.3 current density 2-3-fold, as expected. The cysteine mutants of KChIP2b and -3 were less effective in enhancing functional Kv4.3 channel expression than their respective wild types (Fig.  6, A and C) . However, these mutants produced a change in recovery from inactivation which is similar to those generated by the wild types (Fig. 6, B and D) . These results again demonstrated that the mutants were intact in association with Kv4.3 channels. Furthermore, the subunit composition of functional channel complexes at the cell surface was similar between wild-type and mutant KChIPs. Thus, palmitoylation of the cysteines in the N termini of KChIP2b and KChIP3 is required for their effective enhancement of functional Kv4.3 channel expression at the plasma membrane. Taken together, palmitoylation of KChIPs is an important mechanism for the cell surface localization of associated Kv4 channels.
DISCUSSION
The deletion of the KChIP2 gene results in a complete loss of the transient outward K ϩ current in ventricular myocytes (24) . This finding pointed to the importance of KChIPs in functional Kv4 channel expression in vivo. Although our and others (16, 20, 22, 32) heterologous expression systems exhibit a less dramatic requirement of KChIPs for functional Kv4 channel expression, we show here that the KChIP2 splicing variants differ in their ability to increase the expression of functional Kv4.3 channels. The biochemical and functional analyses revealed that palmitoylation of the N-terminal peptide, which is present only in the two longer isoforms, is responsible for these differences. In addition to the KChIP2 variants, we also demonstrated that palmitoylation of KChIP3 at corresponding sites is essential for its efficient enhancement of functional Kv4.3 channel expression. The longer isoform of KChIP4 also possesses a potential palmitoylation cysteine in its N-terminal region. These results indicate that the palmitoylation of these   FIG. 3 . KChIP2 splicing isoforms similarly influence Kv4.3 channel gating. K ϩ currents were measured in CHO cells transfected with Kv4.3 and KChIP2 splicing variant cDNA or empty vector (None), as described in the legend for Fig. 2, C and D. A, voltage dependence of activation. Conductance was obtained from the data in Fig. 2C . Points represent the means (n Ͼ 6 for each point). B, time dependence of inactivation. Averaged and normalized current trances at 50-mV depolarization pulses are compared (n Ͼ 6 for each trace). Currents were best fitted with one exponential decay. C, steady state inactivation. K ϩ current was elicited by 200-ms depolarization pulse at ϩ40 mV from indicated holding potentials. Peak currents were then compared with that obtained from holding potential of Ϫ70 mV. Points and error bars indicate mean and S.E., respectively (n Ͼ 6 for each point). D, recovery from inactivation. Two depolarization pulses at ϩ40 mV (400 and 50 ms) were elicited with indicated time intervals at Ϫ70 mV. Peak current amplitude of the second pulse (I) was then compared with that of the first pulse (Io). Points and error bars indicate mean and S.E., respectively (n Ͼ 4). Recovery process is best described by one exponential in all cases.
TABLE I Summary of KChIP2 variant-induced changes in Kv4.3 channel gating
Parameters were obtained with the data presented in Fig. 3 
a Values are significantly different (p Ͻ 0.05) compared with None.
auxiliary subunits constitutes an important mechanism that controls the expression of functional Kv4 channels at the cell surface. They also suggest that differential expression of KChIP genes and splicing variants influences the level of functional Kv4 channels in neurons and other excitable cells. Palmitoylation is considered to occur as a secondary process following localization of proteins to the plasma membrane (33) . For example, good substrates for palmitoylation are cysteine residues that are surrounded by basic amino acids. The positive charges seem to be responsible for interaction with the inner surface of the plasma membrane. Likewise, the fatty acylation tends to occur near a membrane-spanning domain of a polypeptide. Therefore, palmitoylation of KChIPs may not act as a targeting or trafficking signal; instead, it is likely that it stabilizes the channel complexes at the plasma membrane. Consistent with this explanation, we observed that the two longer KChIP2 variants with palmitoylation signals caused larger increases in not only Kv4.3 current density but also protein level than the shortest variant which lacks the fatty acylation sites. These parallel increases in current density and channel protein level may be due to the different stabilities of the channel complexes at distinct subcellular compartments.
Although our data demonstrated the involvement of palmitoylation in the expression of functional Kv4.3-KChIP complexes, the fatty acylation cannot account for all the KChIPinduced facilitation of functional channel expression. KChIP2c, which lacks potential palmitoylation sites, and the mutant KChIP2b and -3, in which the fatty acylation sites had been eliminated, were still capable of increasing Kv4.3 current density to lesser degrees. Thus, KChIP binding to Kv4.3 channels increases functional channel expression independently of palmitoylation. Many known channel auxiliary subunits or other interacting proteins lead to increased channel protein and/or current expression. For example, Kv␤ subunits increase functional Kv channel expression by stabilizing the channel complexes (12, 34) . Our data with those KChIPs that lacks the fatty acylation sites support the possibility that these KChIPs acted similarly to Kv␤ subunits to enhance functional channel expression. Therefore, KChIP-induced facilitation of functional Kv4 channel expression may include the following two mechanisms: a palmitoylation-dependent localization at the plasma membrane and a fatty acylation-independent general stabilization of the complexes. Further studies using gene manipulations may be required for determining the contribution of the fatty acylation of KChIPs to functional Kv4 channel expression in vivo.
KChIPs belong to a class of NCS-1 (neuronal Ca 2ϩ sensor, also known as frequenin)-related proteins (35) . One of the common features of these proteins is that they are myristoylated at their N termini (35, 36) . Indeed, all the known NCS-1-related proteins, except KChIP2, -3, and -4, contain the consensus sequence for the N-terminal myristoylation. It is well established that Ca 2ϩ binding to myristoylated proteins regulates their association with membranes by the mechanism named Ca 2ϩ -myristoyl switch (37) ; in the absence of Ca 2ϩ this cotranslationally added fatty acid is folded into the protein and is unable to interact with lipid bilayer; the conformational change associated with Ca 2ϩ binding allows the fatty acid to be exposed and interact with membrane (38) . Although a myristoyl moiety on NCS-1, the most closely related protein to KChIPs, seems to be exposed regardless of Ca 2ϩ binding status (39, 40) , it is possible that Ca 2ϩ binding to KChIP1 also influences the interaction of its associated channel proteins with the plasma and other membranes. Furthermore, the palmitoylation state of some signaling molecules is dynamically regulated by external stimuli and other conditions. Thus, Ca 2ϩ binding or other cellular signals may similarly regulate the palmitoylation state of KChIP2-4. Thus, plasma membrane localization of KChIPs and their associated proteins may also be more dynamically regulated under physiological conditions than generally assumed. Given the lack of acute effects of Ca 2ϩ binding to KChIPs on their associated channels, it would be of particular interest to test if changes in an intracellular Ca 2ϩ concentration may influence localization and expression of KChIP-Kv4 channel complexes.
One of the important consequences of palmitoylation is that palmitoylated (especially multipalmitoylated) proteins are known to accumulate in the detergent-insoluble glycolipid-enriched membrane fractions or lipid rafts (36, 36, (41) (42) (43) (44) (45) . A large number of studies has shown that lipid rafts are enriched with many proteins involved in cellular signaling pathways, such as glycosylphosphatidylinositol-anchored cell adhesion molecules and receptors, G protein-coupled receptors, G proteins, and tyrosine and serine/threonine kinases. Thus, lipid rafts constitute the sites for effective and selective coupling of various signaling molecules. Recent studies (46 -52) have indicated the importance of palmitoylation in the functions of ion channels. For example, palmitoylation of the auxiliary subunit ␤2a of a voltage-gated Ca 2ϩ channel is necessary and sufficient for the unique effects of the subunit on channel gating and G protein-induced modulation (46 -49) . Likewise, the channeland receptor-anchoring protein PSD-95 appears to be one of the major palmitoylated proteins in the brain (50) . Palmitoylation of this protein is essential for its clustering activity. Finally, different voltage-gated K ϩ channels have been shown to localize in distinct populations of lipid rafts; Kv1.5 and Kv2.1 proteins were found in caveolin-and non-caveolin lipid rafts, re- spectively (51, 52) . Thus, palmitoylation and localization in lipid rafts may be important mechanisms for controlling ion channel function. Palmitoylation of KChIPs not only enhances the expression of these channel complexes but may also couple associated channels to specific regulatory proteins by targeting these channel complexes to lipid rafts.
Although it is clear that KChIPs are present in association with Kv4 channels in native cells, these proteins may also FIG. 5 . Palmitoylation of KChIP2b and -3 is required for efficient cell surface localization. A, a part of the second exon of KChIP2 exhibits similarity to G protein receptor kinase 6 (top). Underlined cysteines of GRK6 are known to be palmitoylated. KChIP3 and the longer KChIP4 isoform (17) , as well as the two longer KChIP2 variants, contain potential palmitoylation cysteines. B, the cysteines in KChIP2b and -3 were replaced with alanines (KChIP2b C45,46A and KChIP3 C47,48A). Subcellular localization of wild-type and mutant KChIPs was examined using GFP tagging in the presence (w/Kv4.3) or absence (w/o) of excess Kv4.3 channels, as described in the legend for Fig. 4 . C, association of GFP-KChIPs with myc-Kv4.3 channels was tested by immunoprecipitation, as described previously (12, 27) using a solution containing 1% Triton. Triton extracts and immunoprecipitates with anti-GFP antibody were examined by immunoblot analysis with anti-Myc antibody. Aggregated Kv4.3 proteins were routinely observed in Triton and RIPA buffer extracts, whereas immunoprecipitation eliminated these aggregates. KChIP3 C47A,C48A showed a reduction in myc-Kv4. participate in other cellular functions. KChIP3 has been shown to bind to the downstream DNA element in the prodynorphin gene promoter (25) and the C terminus of presenilins (26) . Because all the known KChIPs, produced either from different genes or by splicing, contain a highly conserved core region, some or all of these proteins may possess the ability to participate in multiple cellular responses. Our empirical demonstration that the two KChIP2 splicing isoforms and KChIP3 are palmitoylated may argue against their having roles in subcellular organella other than plasma membrane. However, it is possible that localization and interaction of KChIPs with distinct proteins may be regulated by depalmitoylation and/or proteolytic digestion (53) , as well as the relative abundance of each KChIP to these interacting partners. Hence, palmitoylation of KChIPs may be an important mechanism for not only controlling channel expression but also to influence the ability of these proteins to participate in other cellular functions, such as transcription and Ca 2ϩ homeostasis.
